Galmed Pharmaceuticals (GLMD) Filings

6-K

GLMD Galmed Pharmaceuticals Ltd

30 Mar 23

Current report (foreign)

4:27pm

SC 13G/A

GLMD Galmed Pharmaceuticals Ltd

14 Feb 23

Galmed Pharmaceuticals / BIOTECHNOLOGY VALUE FUND L P ownership change

12:03pm

6-K

GLMD Galmed Pharmaceuticals Ltd

8 Feb 23

Galmed Announces Issuance of New Composition of Matter Patent for Aramchol meglumine Salt

8:15am

SC 13G/A

Baharaff Allen

7 Feb 23

Galmed Pharmaceuticals / Baharaff Allen ownership change

4:15pm

6-K

GLMD Galmed Pharmaceuticals Ltd

5 Jan 23

Current report (foreign)

4:30pm

6-K

GLMD Galmed Pharmaceuticals Ltd

4 Jan 23

Galmed reports results from the Open-Label part of the ARMOR study showing improvements in histology, imaging, and biomarkers with Aramchol

8:11am

6-K

GLMD Galmed Pharmaceuticals Ltd

14 Dec 22

Current report (foreign)

5:08pm

6-K

GLMD Galmed Pharmaceuticals Ltd

16 Nov 22

Current report (foreign)

5:00pm

6-K

GLMD Galmed Pharmaceuticals Ltd

4 Aug 22

Galmed Pharmaceuticals Provides Business Update and Reports Second Quarter 2022 Financial Results

8:00am

6-K

GLMD Galmed Pharmaceuticals Ltd

7 Jul 22

Galmed Reports Significant Anti-Fibrotic Effects of Aramchol in a Lung Fibrosis Model

8:47am

424B5

GLMD Galmed Pharmaceuticals Ltd

1 Jul 22

Prospectus supplement for primary offering

4:30pm

6-K

GLMD Galmed Pharmaceuticals Ltd

29 Jun 22

Current report (foreign)

4:30pm

6-K

GLMD Galmed Pharmaceuticals Ltd

22 Jun 22

Current report (foreign)

5:00pm

6-K

GLMD Galmed Pharmaceuticals Ltd

17 Jun 22

Galmed Pharmaceuticals Announces Receipt of Nasdaq Minimum Bid Price Notification

4:15pm

6-K

GLMD Galmed Pharmaceuticals Ltd

17 May 22

Current report (foreign)

9:08am

6-K

GLMD Galmed Pharmaceuticals Ltd

17 May 22

Galmed Pharmaceuticals Reports First Quarter 2022 Financial Results

8:20am

6-K

GLMD Galmed Pharmaceuticals Ltd

17 May 22

Galmed updates business and clinical development strategy to better leverage Aramchol’s anti-fibrotic effects

7:51am

6-K

GLMD Galmed Pharmaceuticals Ltd

2 May 22

Galmed Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Year End 2021 Financial

7:07am